Skip to main content
. 2018 Mar 20;11:1563–1570. doi: 10.2147/OTT.S160493

Table 2.

Correlations between HHLA2 expression and clinicopathological parameters of patients with CRC

Characteristic N HHLA2
Low (%) High (%) P-value
Gender 0.414
 Male 39 22 (34.9) 17 (27.0)
 Female 21 11 (17.5) 13 (20.6)
Age 0.374
 ≤64 years 32 15 (23.8) 17 (27.0)
 >64 years 31 18 (28.6) 13 (20.6)
Depth of invasion (T) 0.044
 T2 25 17 (27.0) 8 (12.7)
 T3, T4 38 16 (25.4) 22 (34.9)
Lymph node metastasis ( N) 0.845
 N0 37 19 (30.2) 18 (28.6)
 N1, N2 26 14 (22.2) 12 (19.0)
Distant metastasis (M) 0.063
 M0 60 33 (52.4) 27 (42.9)
 M1 3 0 (0.0) 3 (4.8)
AJCC stage 0.064
 I, II 50 23 (36.5) 27 (42.9)
 III 13 10 (15.9) 3 (4.8)
Smoking history 0.710
 Yes 8 5 (7.9) 3 (4.8)
 No 55 28 (44.4) 27 (42.9)
Alcohol history 1.000
 Yes 7 4 (6.3) 3 (4.8)
 No 56 29 (46.0) 27 (42.9)
CD8 status 0.016
 Negative 32 12 (19.0) 20 (31.7)
 Positive 31 21 (33.3) 10 (15.9)
Total 33 (52.4) 30 (47.6) 63 (100)

Note: Bold figures represent statistically significant P<0.05.

Abbreviation: CRC, colorectal carcinoma.